StockData
PharmaCyte Biotech, Inc. logo

PharmaCyte Biotech, Inc. (PMCB) stock

PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 7/30
$5.37−0.05 (-0.92%)

Close on Nov 18, 2026Market cap $57.65MP/E –Yield –

PharmaCyte Biotech free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for PharmaCyte Biotech

PharmaCyte Biotech has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More PharmaCyte Biotech figures

See a number that looks wrong?